DarioHealth raises $5.1M to speed glucose monitor market adoption

BOSTON – DarioHealth recently announced $5.1 million in aggregate funding. “With this funding, we will accelerate adoption of our innovative and user-friendly remote glucose monitor platform across current markets and also expand into new geographies, such as Germany, in 2017,” said Erez Raphale, DarioHealth chairman and CEO, in a statement. The company will use the funding to promote the platform and further penetrate U.S. and other markets, as well as provide working capital and other general purposes.